Evaluating the safety of Salvia haenkei as a dietary supplement
Official title: Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient in a Healthy Population: a Randomized, Open Label, Parallel-arm, Two-dose Study
Run by IBSA Farmaceutici Italia Srl · NCT05936346 · Data updated 2026-11-12
This study is testing whether taking Salvia haenkei as a dietary supplement is safe for healthy people aged 55 to 65 and if it can help improve their organ functions and overall health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 55 Years to 65 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | IBSA Farmaceutici Italia Srl Industry-sponsored |
| Locations | 1 site (Lugano) |
| Status | Recruiting |
| Started | July 17, 2023 |
| Main results expected | April 30, 2025 |
| Study ends | April 30, 2025 |
| Registry record updated | January 23, 2025 |
| Trial ID | NCT05936346 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are healthy males and females aged 55 to 65 who are willing to maintain their current dietary and exercise habits.
✕Probably not a fit
Patients with a Body Mass Index outside the range of 18.5 to 30 or those with significant medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study assesses the safety and tolerability of Salvia haenkei when taken orally by healthy individuals aged 55 to 65. It aims to explore the potential anti-aging effects of this supplement on various organ functions, including muscular, kidney, liver, and heart functions, as well as its impact on systemic inflammation and metabolism. Participants will receive either 175mg or 350mg of Salvia haenkei and will be monitored for any adverse effects throughout the study.
Why it matters
Potential benefit: If successful, this study could provide a new dietary supplement option to help counteract aging and improve overall health in older adults.
How similar studies have gone: While there is limited data on Salvia haenkei specifically, other studies on dietary supplements targeting aging have shown promising results, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Informed consent as documented by signature * Male or female * Age 55-65 years, inclusive * In good general health as evidenced by medical history and current health status * Willingness to maintain dietary and sports habits as of baseline * Willingness and ability to comply with the requirements of the study Exclusion Criteria: * Body Mass Index \< 18.5 or ≥ 30 * Difficulty in swallowing (dysphagia) * Known allergy or sensitivity to any ingredient of the study intervention * Any medical condition or clinically significant abnormalities in laboratory values (hematology, blood chemistry, urinalysis) at screening which in the judgment of the Investigator makes the subject unsuitable for the study * Planned or anticipated major surgical procedure during the subject's participation in this study * Inability or contraindications to undergo the study intervention * Inability to follow the procedures of the study (e.g. due to language problems, psychological disorders, dementia, etc.) * Use of any new vitamins, herbal or dietary supplements, functional foods and sports drink, of any kind, liable or presented as liable to enhance physical performances within one month prior to the start and during the study
Where it's running
-
Ospedale Regionale di Lugano
Lugano, Switzerland Recruiting
Study contacts
- Principal investigator: Roberta Noseda, MD, PhD — Istituto di Scienze Farmacologiche della Svizzera Italiana, Lugano (Switzerland)
- Study coordinator: Tatiana Terrot
- Email: Tatiana.Terrot@eoc.ch
- Phone: +41 91 811 7962
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Aquatic power training dosing strategies and creatine in older adults
This trial tests whether different aquatic power training dosing methods and creatine supplementation help improve function in community-dwelling adults aged 60 and older.
-
Intergenerational Interaction Program for Nursing Home Residents and Nursing Students
A 6-week program pairs nursing home residents with nursing students to see if weekly joint activities can increase joy and reduce loneliness for older adults and lessen ageism in students.
-
Supplemental Mobility for older adults in skilled nursing facilities
This pilot tests whether adding a mobility aide to support walking and transfers alongside regular rehab helps older adults in SNFs after hospitalization see more daily activity and safer mobility.
-
Smart Voice Platform to Support Quality of Life for Community-Living Older Adults
A smart voice platform is tested to see if it improves quality of life and healthy aging for older adults living in the community.
-
Digital STEADI: A home-based digital fall prevention program for older adults
A home-based digital program using AI-driven conversational agents tests if a guided fall-prevention exercise plan can reduce fall risk for older adults with mild cognitive impairment living independently.
-
Sex hormones, menopause, and exercise in aging women
This study tests how hormonal status and resistance training affect age-related muscle and nerve function in postmenopausal women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.